TVGN
Tevogen Bio Holdings Inc.
7.40$
-4.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| – | +1.1% | -28.9% | -37.1% | +26.6% | |
| – | -18.6% | -70.5% | +37.0% | -34.8% | |
| – | -23.0% | -80.8% | +21.9% | -56.9% | |
| – | -23.0% | -80.8% | +21.9% | -56.9% | |
| – | – | – | -53.9% | +0.0% | |
| – | +72.7% | +139.7% | -89.9% | +24.5% | |
| – | +193.5% | +4,260.1% | -89.4% | -21.8% | |
| – | – | +29,002.3% | -97.7% | +5.2% | |
| – | +129.1% | +294.8% | +52.1% | -35.8% | |
| – | +67.4% | -63.8% | -93.0% | +340.0% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | +150.3% | +37.9% | -11.3% | +13.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.